洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR-ROC-16010045】鼻敏感患者的鼻尖峰吸氣流量與睡眠質素之關係

基本信息
登记号

ChiCTR-ROC-16010045

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2016-11-21

临床申请受理号

/

靶点

/

适应症

Allergic rhinitis

试验通俗题目

鼻敏感患者的鼻尖峰吸氣流量與睡眠質素之關係

试验专业题目

鼻敏感患者的鼻尖峰吸氣流量與睡眠質素之關係

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

鼻敏感患者的鼻尖峰吸氣流量與睡眠質素之關係

试验分类
试验类型

单臂

试验分期

其它

随机化

NA

盲法

/

试验项目经费来源

Department of Otorhinolaryngology, Head and Neck Surgery, CUHK

试验范围

/

目标入组人数

60

实际入组人数

/

第一例入组时间

1990-01-01

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

1. Both genders of 18 years and over; 2. Abbreviated Mental Test>=6; 3. Ability to understand the nature, scope and possible consequences of the study; 4. Capability and willingness to comply with the requirements of the protocol.;

排除标准

1. With co-existing nasal conditions other than AR, which may affect nasal pathology (nasal polyposis, sinusitis, severe deviations of nasal septum, tumours of the nasal cavity, acute/chronic rhinosinusitis, or any underlying pathology that might affect nasal breathing or nocturnal sleep); 2. With prior nasal surgery eg. surgery performed in nasal cavity, sinuses; 3. History of known sleep disorder, central and obstructive sleep apnoea, narcolepsy, insomnia, patients requiring regular sleep medication and those hypersensitive to applied topical nasal steroids; 4. Respiratory tract infection within the past 30 days; 5. Clinically major cardiovascular, respiratory, hepatic, neurological, endocrine, immunological, or other major systemic diseases; 6. History of drug or alcohol abuse; 7. On concurrent immunosuppressive therapy or systemic steroid treatment; 8. On other medications that could affect nasal/ocular symptoms, sleep/daytime performance eg. decongestants, anti-inflammatory drugs, oral/long acting inhaled beta-agonist, sleeping pills; 9. On self-prescribed rhinitis or sleep medication; 10. Unable to perform PNIF by himself/herself.;

研究者信息
研究负责人姓名
试验机构

The Chinese University of Hong Kong

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

The Chinese University of Hong Kong的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品

同适应症药物临床试验